References
- El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43:327–33.
- Paimela H, Joutsi T, Kiviluoto T, Kivilaakso E. Recent trends in mortality from peptic ulcer in Finland. Dig Dis Sci 1995;40: 631–5.
- Borody TJ, Brandl S, Andrews P, Jankiewicz E, Ostapowicz N. Helicobacter pylori-negative gastric ulcer. Am J Gastroenterol 1992;87:1403–6.
- Hyvärinen H, Salmenkylä S, Sipponen P. Helicobacter pylori-negative duodenal and pyloric ulcer: role of NSAIDs. Digestion 1996;57:305–9.
- Somerville K, Faulkner G. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;March 1:462–4.
- Walt R, Katschinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986;March 1:489–92.
- Kurata JH, Abbey DE. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 1990;12:260–6.
- Chan FKL, Sung JJY, Chung SCS, To KF, Yung MY, Leung VKS, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent eptic ulcers. Lancet 1997;350:975–9.
- Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in long-term NSAID users. Response to omeprazole dual therapy. Gut 1996;39:22–6.
- Hawkey CJ, Tulassay Z, Szczepanski L, van Rensburg CJ, Filipowicz-Sosnowska A, Lanas A, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on nonsteroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet 1998;352: 1016–21.
- Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991;6:209–22.
- Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115:787–96.
- Heresbach D, Raoul JL, Bretagne JF, Minet J, Donnio PY, Ramee MP, et al. Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy. Gut 1992;33:1608–11.
- Taha AS, Sturrock RD, Russell RI. Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut 1995;36: 334–6.
- Li EKM, Sung JJY, Suen R, Ling TK, Leung VK, Hui E, et al. Helicobacter pylori infection increases the risk of peptic ulcers in chronic users of non-steroidal anti-inflammatory drugs. Scand J Rheumatol 1996;25:42–6.
- Voutilainen M, Sokka T, Juhola M, Farkkila M, Hannonen P. Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Scand J Gastroenterol 1998;33:811–6.
- Stack WA, Hawkey GM, Atherton JC, Pearson G, Everitt S, Fielding K, et al. Good and bad Helicobacter: CagA status and NSAID use as independent risk factors for peptic ulcer bleeding. Gut 1998;42 Suppl 1:A3.
- Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Am J Gastroenterol 1998;93:2037–46.
- Raskin JB. Gastrointestinal effects of nonsteroidal anti-inflammatory therapy. Am J Med 1999;106:3S–12S.
- Lichtenstein DR, Syngal S, Wolfe MM. Non-steroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheum 1995;38:5–18.
- Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in Greater Rochester, NY: Is empirical triple therapy justified? Am J Gastroenterol 1998;93: 574–8.
- Chan HLY, Wu JCY, Ching JYL, Chan FKL, Lau JWY, Chung SCS, et al. Non-H. pylori, non-NSAID peptic ulcer is a rare cause of gastrointestinal bleeding. A prospective study of 977 Chinese patients. Gastroenterology 1999;116:A134.
- Anonymous. Guidelines for clinical trials in H. pylori infection. Gut 1997;41 Suppl 2:S1–23.
- Sipponen P, Kekki M, Seppälä K, Siurala M. The relationships between chronic gastritis and gastric acid secretion. Aliment Pharmacol Therap 1996;10 Suppl 1:103–18.
- Sobala GM, King RFG, Axon ATR, Dixon MF. Reflux gastritis in the intact stomach. J Clin Pathol 1990;43:303–6.
- El-Zimaity HMT, Genta RM, Graham DY. Histological features do not define NSAID-induced gastritis. Hum Pathol 1996;27: 1348–54.
- Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Färkkilä M, Haapiainen R, et al. Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis. J Clin Microbiol 1998;36:1808–10.